Pantothenic Acid for Health & Longevity - Quick Reference Sheet
evipedia.aidev
← Back

Pantothenic Acid for Health & Longevity

Created on 08/22/2026 – Quick Reference based on Evidence Review created using AI4L / Grok 4 – Audit

On mixed diets the adult need is about five milligrams a day. Gram doses, pantethine, and panthenol creams are not a general longevity intervention. Pantethine is a modest tool for artery-clogging lipid particles; panthenol creams can help a damaged skin barrier. Multi-gram calcium pantothenate causes diarrhea; panthenol cosmetics can trigger contact allergy. (Full Review)

Protocol

Dietary baseline
5 mg/day
6 mg pregnancy, 7 mg lactation; typically met by liver, eggs, mushrooms, avocado, yogurt, and whole grains, or by a multivitamin at 100% Daily Value
Pantethine lipid protocol
600 then 900 mg/day
For 8 weeks each, in divided doses with a lipid-lowering diet
Topical dexpanthenol
5% cream or ointment
Leave-on, often twice daily on intact or superficially injured skin
Time to effect
Deficiency symptoms
Days to weeks
Reverse after repletion
Topical barrier effects
Within days
Skin-barrier repair
Pantethine lipid changes
4–8 weeks
On a lipid-lowering diet

Benefits

Contraindications
  • Known allergy to dexpanthenol, panthenol, or calcium pantothenate (absolute for that form)
  • Unexplained eosinophilia or recent unexplained pleural or pericardial effusion while using high-dose B5 plus biotin (caution until evaluated)
    •
Key Interactions
  • Statins and niacin (caution, additive lipids; atorvastatin, rosuvastatin, nicotinic acid)
  • Oral contraceptives (caution, higher requirement)
  • Tetracycline antibiotics (caution, absorption; doxycycline, minocycline)
  • Cholinesterase inhibitors (monitor, theoretical cholinergic additivity; donepezil, rivastigmine)
  • Biotin and lipoic acid (caution, shared SMVT)
  • Other B-complex products (caution, hidden B6)
    •

Risk & Side Effects

  • High: Watery diarrhea and gastrointestinal upset
    •
  • Medium: Allergic contact dermatitis from topical dexpanthenol
    •
  • Low: Eosinophilic pleuropericardial effusion
    •
  • Speculative: Fueling MYC-high tumor coenzyme A metabolism; Competition with biotin at SMVT
    •

Monitoring

Marker Target Why
Urinary pantothenic acid >1 mg/day Adequacy marker used for the adult adequate intake
Whole-blood pantothenate 1.6–2.7 µmol/L Reflects circulating vitamin better than a single plasma draw
LDL-C (if using pantethine) Often <70–100 mg/dL in prevention clinics Tracks the modest LDL-C effect of pantethine
apoB (if using pantethine) Often <80–90 mg/dL in prevention clinics Particle number, more informative than LDL-C alone
CBC and hepatic panel (gram-dose protocols) No established target; track stability versus the person's own baseline Safety labs used in the 2.2 g/day acne RCT

Cadence: Baseline: diet recall; lipid panel with apoB if the goal is lipids; CBC and hepatic panel for gram-dose acne. Pantethine: lipids and apoB at 8 and 16 weeks, then every 6–12 months if continued. Gram-dose acne protocols: lesion counts and safety labs at 12 weeks. Dietary-adequacy use does not require recurring B5 blood tests; a yearly multi-ingredient panel is enough. Qualitative markers are checked continuously.

Qualitative Assessment

  • Resolution of burning feet, paresthesias, unexplained fatigue, or insomnia if those began in a low-intake setting
  • Skin-barrier comfort and wound appearance with topical dexpanthenol
  • Facial inflammatory lesion count if a gram-dose acne protocol is used
  • Stool frequency and cramping after any dose increase
  • No new dyspnea (shortness of breath), chest pain, or rash after high-dose B5 plus biotin
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.